Independent Financial Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
Independent Financial Group's SBIO Position: Q2 2026 in Review
Independent Financial Group increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 3.2% in Q2 2026, buying an estimated $10.6K and bringing the position to 6,190 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #1083.
Independent Financial Group first reported a position in SBIO in Q3 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Independent Financial Group held 6,190 shares of ALPS Medical Breakthroughs ETF worth $400K as of Q2 2026.
- Independent Financial Group bought 194 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $10.6K.
- ALPS Medical Breakthroughs ETF made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1083 holding.
- Independent Financial Group first reported a position in ALPS Medical Breakthroughs ETF in Q3 2025 and has held it in 4 quarters since.
- 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.